SCHEMBL4327360

SCHEMBL4327360

CCN(CC)Cn1ccnc1C(N)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.33
TLR8 Q9NR97 2/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
ALDH1A1 P00352 3/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
PIM1 P11309 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
ALPG P10696 1/20 0.31
PLAA Q9Y263 1/20 0.31
ARG1 P05089 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
PKM P14618 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4333586 0.85 SMN1; SMN2 (0.33) HTTTLR8SMN1; SMN2NPC1RAB9A
SCHEMBL4314338 0.82 SMN1; SMN2 (0.39) TLR8SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL27845254 0.79 TLR8 (0.42) TLR8SMN1; SMN2ALDH1A1POLBKMT2A
SCHEMBL3810263 0.75 ALDH1A1 (0.35) SMN1; SMN2NPC1RAB9AALDH1A1ARG1
SCHEMBL7481370 0.73 KMT2A (0.53) HPGDALDH1A1POLBKMT2AALPG
SCHEMBL31210326 0.72 ARG1 (0.39) TLR8SMN1; SMN2RAB9AALDH1A1PIM3
SCHEMBL7362579 0.71 ALDH1A1 (0.33) SMN1; SMN2NPC1RAB9AALDH1A1KMT2A
SCHEMBL18839651 0.70 KDM4E (0.44) SMN1; SMN2NPC1ALDH1A1POLBKMT2A
SCHEMBL7557979 0.69 TLR8 (0.37) TLR8HPGDALDH1A1POLBKMT2A
SCHEMBL28205879 0.69 CYP11B1 (0.42) HTTHPGDSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009141386-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2009-11-26 WO disclosed